February 15, 2022 — Vaccine-associated myocarditis shows a similar injury pattern on cardiac MRI compared to other causes of myocarditis, but abnormalities are less severe, according to a new study published in the journal Radiology.

February 15, 2022 – Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University’s Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

February 15, 2022 — Viz.ai and TeleSpecialists, LLC  have entered a strategic partnership that will bring AI-powered stroke care together with leading telestroke neurologists to optimize time to treatment and improve patient outcomes across the United States.

February 15, 2022 — The leaders of three of the nation’s leading cardiology groups – American Heart Association President Donald M. Lloyd-Jones, M.D., Sc.M., FAHA; American College of Cardiology President Dipti Itchhaporia, MD, FACC and Association of Black Cardiologists Michelle A. Albert, MD, MPH – issued the following statement expressing support for the nomination of Robert M. Califf, M.D. as commissioner of the Food and Drug Administration (FDA) and urging a timely Senate confirmation vote:

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies, has announced the launch of EMBOGUARD, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

February 15, 2022 — UC Davis pediatric electrophysiologist

February 15, 2022 – The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) have announced the first-ever industry framework to evaluate and give guidance for consumer devices or applications designed to improve cardiovascular health. CTA and ACC have convened health and technology industry leaders to advance guidance and best practices for cardiovascular health technology developers and companies.

February 15, 2022 – Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) refinements and three new high-value tools. These updates come in the midst of American Heart Month and allow Cleerly technology to enter into the clinical workflows of health systems and providers across the U.S., drive new efficiencies, and deliver new insights to customers.

February 15, 2022 - Fivos Inc., formerly known as Medstreaming/M2S, a leading company providing comprehensive data solutions for specialty providers, medical registries and device manufacturers, announced the spin-off of its imaging services business into Astute Imaging. The new company will focus on adopting state-of-the-art artificial intelligence (AI) and cloud technologies to advance its unique patented imaging software and enable precision medicine for healthcare providers and device companies.

February 14, 2022 – MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics), a national remote monitoring provider and technology leader in deep learning artificial intelligence, has announced a partnership with the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH)-fu

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now